role of the research regulatory agencies irbs
play

Role of the research regulatory agencies-IRBs 1 B R AN D O N B R - PowerPoint PPT Presentation

Role of the research regulatory agencies-IRBs 1 B R AN D O N B R O W N D I R E C TO R O F G H R E AT U C I RV I N E P R O G R AM I N P U B L I C H E ALT H I RV I N E , C A U S A IRBs 2 IRB=Institutional Review Board (ethics


  1. Role of the research regulatory agencies-IRBs 1 B R AN D O N B R O W N D I R E C TO R O F G H R E AT U C I RV I N E P R O G R AM I N P U B L I C H E ALT H I RV I N E , C A U S A

  2. IRBs 2 � IRB=Institutional Review Board (ethics committee) � created as a direct response to Nuremberg and Tuskeegee � safeguard the rights, safety, and well-being of trial subjects � 3 ethical principles in the Belmont report � Beneficence, justice, respect � Voluntary study participation � Declaration of Helsinki � Distinction between care and research � HIV testing and treatment • research or care?

  3. IRB function 3 � Gatekeepers to starting your study � Nothing happens without IRB approval � Human subjects protection focus � They don’t try to change science � Investigators often don’t like IRB applications � Cumbersome � Causes delays in starting studies � Barrier to funding � BUT � They help protect the PI and also the University � Lawsuits, ethical violations, etc

  4. Criteria for IRB Approval-UCI 4 45 CFR 46.111, 21 CFR 56.111 BENEFICENCE JUSTICE Subject Selection Experimental Design Risk/Benefit Analysis Inclusion/exclusion Data Safety Recruitment Qualifications of Researchers Fair Distribution RESPECT FOR PERSONS Privacy & Confidentiality Vulnerable Populations Informed Consent Surrogate Consent Parent Permission / Assent

  5. IRBs-Specific attention in reviewing HIV Prevention Protocols � Cultural issues � sensitivity to the environment the research would be conducted in, and the specific subject population � How are ppl w HIV treated/viewed/respected? � Subject privacy issues � how prospective subjects are approached for participation � Assumed high risk group-approached in public � Participation=stigma (known HIV study) � Confidentiality of data � risk to subjects if exposed as involved in HIV prevention study � Stigma, criminal charges, death, loss of social status/employment

  6. Specifics to HIV protocols continued-consent � Consent � Understandability � Risk and benefits � Clinical trial may not actually lead to prevention of HIV � Re-consenting over long periods � Longitudinal understanding • how vaccine study affects rapid HIV test results � Tell all potential risks � ‘illness/death is possible from the drug/vaccine � Sample use � Future research for HIV related work?

  7. IRB approval! 7 � Usually approval pending other site approvals � For studies in several countries � The last time you need to deal with the IRB? � Think again � Amendments common � Report adverse events as they occur � Scientific advances � Research today=standard of care tomorrow � How to make the transition � The audit-deviations and misconduct � Someone from IRB sent to oversee activities � Can pull the plug on your study

  8. MISCONDUCT in HIV prevention projects (breaking the rules) 8 � Study not occurring � Money being spent/pocketed � Maintaining bad records � No security � Appropriate amount of time � Or no records � Misrepresenting speculation as fact to participants � ‘Sure this vaccine/treatment will work’ � Changing randomization assignment � Feel that it will help this person

  9. Preventing misconduct (Oversight Needs) � Ethics violations � during implementation of the research, management at the study site, or study closure � IRB role � May observe the consent process and/or the research � May embargo of publications/presentations � May suspend or terminate approval of research � not conducted in accordance with the regulations � Post approval monitoring (PAM) to identify violations at an early stage � Threat of IRB oversight can prevent violations � IRB has this option

  10. PAM in HIV Prevention Research � In HIV research taking place in another country, a site visit from a collaborating IRB is more difficult � Potential barrier to regulatory oversight � barrier may be overcome by the use of digital technologies � most of the world has at least remote access to the internet � Skype, face time, google chat

  11. Use of PAM Technology in HIV Prevention research � Reduced expenses and facilitation of communication � Save on the cost of an in person visit-air ticket every X months � May further help reduce ethical violations � Communication is key � Funds written into grants to support technology needed for PAM and to provide human subjects training to research collaborators � Consider as a requirement for future federally funded international research � Creation of PAM Ambassadors at IRBs and research sites � One option we have to make our studies more ethical

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend